Verrica Pharmaceuticals Inc. Quarterly Interest Expense in USD from Q1 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Verrica Pharmaceuticals Inc. quarterly/annual Interest Expense history and growth rate from Q1 2020 to Q2 2024.
  • Verrica Pharmaceuticals Inc. Interest Expense for the quarter ending June 30, 2024 was $2.37M.
  • Verrica Pharmaceuticals Inc. Interest Expense for the twelve months ending June 30, 2024 was $8.65M, a 35938% increase year-over-year.
  • Verrica Pharmaceuticals Inc. annual Interest Expense for 2023 was $3.96M, a 82.4% increase from 2022.
  • Verrica Pharmaceuticals Inc. annual Interest Expense for 2022 was $2.17M, a 49.4% decline from 2021.
  • Verrica Pharmaceuticals Inc. annual Interest Expense for 2021 was $4.3M, a 41.6% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $8.65M $2.37M +$2.37M Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $6.28M $2.32M +$2.32M Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $3.96M $2.31M +$2.36M Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 $1.6M $1.66M +$1.58M +1946% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $24K $0 -$1.07M -100% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 $1.09M $0 -$1.08M -100% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 $2.17M -$57K -$1.16M -105% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 $3.33M $81K -$1.01M -92.6% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $4.34M $1.07M -$11K -1.02% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $4.35M $1.08M +$54K +5.25% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $4.3M $1.1M +$106K +10.7% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-06
Q3 2021 $4.19M $1.09M +$174K +19% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 $4.02M $1.08M +$173K +19.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $3.84M $1.03M +$808K +367% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 $3.03M $992K Oct 1, 2020 Dec 31, 2020 10-K 2022-03-02
Q3 2020 $918K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $904K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-10
Q1 2020 $220K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.